Genmab A/S

Genmab A/Sverified

GMAB.CO

Price:

$1518

Market Cap:

$96.40B

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating sol...[Read more]

Industry

Biotechnology

IPO Date

2000-10-20

Stock Exchange

CPH

Ticker

GMAB.CO

The Enterprise Value as of November 2024 (TTM) for Genmab A/S (GMAB.CO) is 93.09B

According to Genmab A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 93.09B. This represents a change of -26.70% compared to the average of 127.00B of the last 4 quarters.

Genmab A/S (GMAB.CO) Historical Enterprise Value (quarterly & annually)

How has GMAB.CO Enterprise Value performed in the past?

The mean historical Enterprise Value of Genmab A/S over the last ten years is 98.45B. The current 93.09B Enterprise Value has changed 9.36% with respect to the historical average. Over the past ten years (40 quarters), GMAB.CO's Enterprise Value was at its highest in in the December 2022 quarter at 182.96B. The Enterprise Value was at its lowest in in the September 2014 quarter at 13.91B.

Quarterly (TTM)
Annual

Average

98.45B

Median

79.92B

Minimum

19.93B

Maximum

183.01B

Genmab A/S (GMAB.CO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genmab A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 165.00%

Maximum Annual Enterprise Value = 183.01B

Minimum Annual Increase = -30.80%

Minimum Annual Enterprise Value = 19.93B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023126.65B-30.80%
2022183.01B11.96%
2021163.46B6.42%
2020153.59B70.83%
201989.91B44.46%
201862.24B-1.24%
201763.01B-9.89%
201669.93B32.39%
201552.82B165.00%
201419.93B87.30%

Genmab A/S (GMAB.CO) Average Enterprise Value

How has GMAB.CO Enterprise Value performed in the past?

The current Enterprise Value of Genmab A/S (GMAB.CO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

157.70B

5-year avg

143.32B

10-year avg

98.45B

Genmab A/S (GMAB.CO) Enterprise Value vs. Peers

How is GMAB.CO’s Enterprise Value compared to its peers?

Genmab A/S’s Enterprise Value is greater than Ambu A/S (34.00B), less than DSV A/S (368.86B), greater than Bavarian Nordic A/S (15.58B), greater than GN Store Nord A/S (30.88B), greater than FLSmidth & Co. A/S (21.39B),

CompanyEnterprise ValueMarket cap
34.00B$33.92B
368.86B$353.19B
15.58B$16.27B
30.88B$19.56B
21.39B$20.23B

Build a custom stock screener for Genmab A/S (GMAB.CO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genmab A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genmab A/S (GMAB.CO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genmab A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Genmab A/S's Enterprise Value?

What is the highest Enterprise Value for Genmab A/S (GMAB.CO)?

What is the 3-year average Enterprise Value for Genmab A/S (GMAB.CO)?

What is the 5-year average Enterprise Value for Genmab A/S (GMAB.CO)?

How does the current Enterprise Value for Genmab A/S (GMAB.CO) compare to its historical average?